Exchange: NASDAQ·Updated 07:52 PM EDT
APVO logo

APVO Aptevo Therapeutics Inc

$1.79
$0.01
(0.56%)
Today
Closed $1.79
$0.01
(0.56%)
After Hours
Mkt Cap$3.24M
Vol6,821.00

About APVO

Aptevo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages on developing novel immunotherapies for the treatment of cancer. Its pipeline APVO436, ALG.APV-527, and APVO603 were developed based on the ADAPTIR modular protein platform technology and APVO442 was developed based on the new ADAPTIR-FLE platform technology. The ADAPTIR and ADAPTIR-FLEX are capable of generating differentiated bispecific and multi-specific antibodies with potentially unique mechanisms of action for the treatment of different types of cancer. The company was founded in February 2016 and is headquartered in Seattle, WA.
59

Bullish Sentiment

How do you feel about APVO?

Quagglerock
$APVO Current market cap around $3 million. You tell me where this is headed once they secure a partner for Mipletamig.
1
Quagglerock
$APVO Okay, form S-8 now filed and incentive shares are registered. Look for stock awards to be made soon. Additionally, the PIPE and inducement shares have been approved for registration. Look for this to blast off soon after.
1
Quagglerock
$APVO I suspect we’re going to see both an asset sale (527) and a licensing partnership on Mipletamig. They are 50/50 owners on 527. Alligator desperately needs the money and this is the cleanest way to do it - simply split the purchase price. Those two deals would make cash management and further dilution become irrelevant for the foreseeable future.
1
focafoca99
$APVO concluded its special meeting with shareholder approval of four proposals, including a new stock incentive plan and charter amendment.
1
Planktont
Wow, Big traders calling MLEC for a squeeze! Looks like he is right again, Loads of bulls shifting to MLEC now! 🚀 The next parabolic low float runner? All eyes on MLEC breaking out $APVO zzx

Advertisement|Remove ads.